ÌÇÐÄvlog´«Ã½

Helicobacter Pylori Diagnostics Market Analysis

The helicobacter pylori diagnostics market is expected to register a CAGR of 7.2% over the forecast period.

The outbreak of the COVID-19 pandemic has pushed the medical device industry into action, with a race to develop both therapeutic and preventive devices. Exponentially increasing cases of the coronavirus worldwide are leading to the need for the development of novel treatments, with several clinical trials underway. Meanwhile, the manufacturers of diagnostic devices were highly focused on developing vaccines and drugs, which can also be applied in the diagnosis and treatment of COVID-19, increasing the rate of clinical trials to a great extent. The outbreak of the pandemic increased the cases of gastrointestinal diseases and other infectious diseases. For instance, as per the study titled, "Impact of Gastrointestinal Symptoms in COVID-19: a Molecular Approach" published in November 2020, the gastrointestinal tract gets affected by COVID-19. It also reported that the gastrointestinal tract is considered the replication site for SARS-CoV-2. In addition, it also stated that the severity in patients suffering from COVID-19 increases who are already having gastrointestinal disorders. Helicobacter pylori diagnostics is one of the common diagnostic procedures for gastrointestinal disorders, therefore, the market witnessed a considerable growth during the pandemic.

The rising prevalence of infectious diseases and increasing awareness about the infections among people are the major drivers for the market. The most common infectious diseases caused by bacteria are Tuberculosis, Chlamydia, gonorrhea, other sexually transmitted diseases (STDs), Stomach flu (gastroenteritis), and Urinary tract infections (UTIs). For instance, according to the study titled, "The Global Prevalence of Peptic Ulcer in the World: a Systematic Review and Meta-analysis" published in December 2021, the global prevelence of peptic ulcer was around 8.4% in 2021. Similarly, as per the report published by the Medscape in April 2021, peptic ulcer disease affects approximately 4.6 million people annually in the United States. Similarly, according to the report published by the European Centre for Disease Prevention and Control in March 2021, it was reported that every year around 500,000 sexually transmitted infections are detected in the European Union, European Economic Area (EEA), and the United Kingdom. Since, helicobacter pylori diagnostics are generally recommended for the diagnostic of infectious diseases, therefore, such instances indicate that the market is expected to show significant growth rate over the forecast period.

However, stringent regulatory norms by government may likely to restrain the market growth over the forecast period.

Helicobacter Pylori Diagnostics Market Trends

This section covers the major market trends shaping the Helicobacter Pylori Diagnostics Market according to our research experts:

Immunoassay Segment is Expected to Witness Growth Over the Forecast Period

Helicobacter Pylori Diagnostics Industry Segmentation

As per the scope of the report, helicobacter pylori is a gram-negative aerobic bacterium commonly found in the stomach which plays a key role in balancing stomach ecology. The Helicobacter Pylori Diagnostics Market is segmented by Technology (Immunoassays, Point of Care (POC), Molecular Diagnostics, and Others), End User (Hospitals and Clinics, Diagnostics Laboratories, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.